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The infectious cycle of primate lentiviruses is intimately linked to interactions between cells of the immune system.
Nef, a potent virulence factor, alters cellular environments to increase lentiviral replication in the host, yet the
mechanisms underlying these effects have remained elusive. Since Nef likely functions as an adaptor protein, we
exploited a proteomic approach to directly identify molecules that Nef targets to subvert the signaling machinery in T
cells. We purified to near homogeneity a major Nef-associated protein complex from T cells and identified by mass
spectroscopy its subunits as DOCK2–ELMO1, a key activator of Rac in antigen- and chemokine-initiated signaling
pathways, and Rac. We show that Nef activates Rac in T cell lines and in primary T cells following infection with HIV-1 in
the absence of antigenic stimuli. Nef activates Rac by binding the DOCK2–ELMO1 complex, and this interaction is
linked to the abilities of Nef to inhibit chemotaxis and promote T cell activation. Our data indicate that Nef targets a
critical switch that regulates Rac GTPases downstream of chemokine- and antigen-initiated signaling pathways. This
interaction enables Nef to influence multiple aspects of T cell function and thus provides an important mechanism by
which Nef impacts pathogenesis by primate lentiviruses.
Introduction
Primate lentiviruses persist in the host by active replication
and can reemerge from latent reservoirs that are established
in cells of the immune system (Finzi and Siliciano 1998;
Douek et al. 2003). The infectious cycle is intimately linked to
interactions between circulating T cells and antigen-present-
ing cells (Stevenson et al. 1990; Bukrinsky et al. 1991;
Embretson et al. 1993; Swingler et al. 1999; Geijtenbeek et
al. 2000). These interactions involve T cell migration,
adhesion, and antigen-initiated signaling, processes that are
dependent on cytoskeletal dynamics regulated by the Rho
subfamily of small GTPases (Hall 1998; Schmitz et al. 2000).
The lentiviral accessory protein Nef is a multifunctional
regulator that is important for rapid progression to AIDS
(Kestler et al. 1991; Piguet et al. 1999; Renkema and Saksela
2000). One key function of Nef is its ability to facilitate
activation of infected cells and thus provide an environment
that is conducive for viral replication (Skowronski et al. 1993;
Baur et al. 1994; Du et al. 1996; Schrager and Marsh 1999;
Simmons et al. 2001). Another important function of Nef is
its ability to promote evasion of the antiviral immune
response. This is accomplished by downregulation of class I
MHC complexes from the surface of infected cells, which
protects against detection by cytoxic T cells speciﬁc for viral
antigens (Schwartz et al. 1996; Collins et al. 1998).
The ability of Nef to facilitate T cell activation is well
documented. Thymic and peripheral CD4þ T cells from
transgenic mice are hypersensitive to stimulation via the T
cell antigen receptor (TCR) (Skowronski et al. 1993; Hanna et
al. 1998), as are resting primary human CD4þT cells (Schrager
and Marsh 1999; Wang et al. 2000) and cell lines transduced to
express HIV-1 Nef (Alexander et al. 1994; Baur et al. 1994).
Nef was reported to associate with molecules that play
important roles in antigen-initiated signaling in T cells,
including elements of signaling pathways involving small
GTPases. Speciﬁcally, Nef was reported to associate with Vav
(Fackler et al. 1999) and activate p21-activated serine–
threonine kinases (PAKs), possibly though the activation of
Rac or CDC42 (Lu et al. 1996). Recent observations that Nef
can activate Rac in a glial cell line have strengthened the
connection between Nef and these pathways (Vilhardt et al.
2002). The notion that effects of Nef on signaling machineries
in T cells are mediated by small GTPases, their effectors, or
both represents an attractive possibility, yet the exact
mechanism resulting in activation of these pathways has
remained elusive. Since Nef likely functions as an adaptor
protein, we exploited a proteomic approach to directly
identify the key molecules Nef uses to subvert the signaling
machinery in T cells. Here we show that Nef targets a key
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activator of Rac GTPases that functions downstream of the
TCR and chemokine receptors.
Results
Nef Binds DOCK2, ELMO1, and Rac in T Cells
To identify downstream effectors of Nef in T lymphocytes,
we generated CD4þ Jurkat T cells that stably express the
extensively studied patient-derived HIV-1 Nef protein NA7
(Mariani and Skowronski 1993) tagged at its C-terminus with
HA and FLAG epitopes (NA7-hf) (Figure 1A). Nef and its
associated proteins were puriﬁed by successive immunopre-
cipitations with anti-HA- and then anti-FLAG epitope anti-
bodies, followed each time by elution with the respective
peptide epitope and resolved by SDS-PAGE. Several poly-
peptides with apparent molecular weights ranging from
approximately 20 kDa to 220 kDa copuriﬁed with HIV-1
Nef, but were absent in preparations from control cells that
do not express Nef (Figure 1B). Gel slices containing these
polypeptides were digested with trypsin, and the resulting
peptides were sequenced by liquid chromatography tandem
mass spectroscopy (LC/MS/MS) and subjected to database
searches (Hu et al. 2002). Two abundant Nef-associated
proteins, DOCK2 and ELMO1, were thus identiﬁed. DOCK2
is a lymphocyte-speciﬁc CED5/DOCK180/Myoblast City
(CDM) family protein that regulates the activity of Rac1 and
Rac2 GTPases downstream of chemokine receptors and the
TCR and is essential for lymphocyte migration and normal
antigen-speciﬁc responses of T cells (Fukui et al. 2001; Reif
and Cyster 2002; Sanui et al. 2003a). Rac GTPases are
members of the Rho subfamily of small GTP-binding proteins
that control several processes, including cytoskeletal rear-
rangements during cell motility and T cell activation (Hall
1998). Recent studies showed that ELMO1 functionally
cooperates with CDM family proteins to activate Rac
(Brugnera et al. 2002; Sanui et al. 2003b). Signiﬁcantly, our
mass spectroscopic analyses of Nef-associated proteins also
identiﬁed Rac2. Furthermore, in addition to Rac2-speciﬁc
peptides, we also detected peptides shared by Rac1 and Rac2,
raising the possibility that Rac1 also associates with HIV-1
Nef in T cells. The ubiquitously expressed Rac1 and
hematopoietic cell-speciﬁc Rac2 are 95% identical, and both
isoforms regulate cytoskeletal dynamics and gene expression
in T lymphocytes (Yu et al. 2001; Croker et al. 2002).
Nef Binds the DOCK2–ELMO1–Rac Complex
By analogy to previously described interactions among Rac,
ELMO1, and CDM family proteins (Brugnera et al. 2002;
Sanui et al. 2003b), our ﬁnding that DOCK2, ELMO1, and
Rac2 copuriﬁed with HIV-1 Nef suggested that DOCK2 forms
a ternary complex with ELMO1 and Rac2 and that Nef binds
this complex. To investigate these possibilities, we attempted
to reconstitute these interactions in human embryonic
kidney 293 (HEK 293) cells. Although HEK 293 cells express
endogeneous ELMO1, our initial studies revealed that the
association of Nef with DOCK2 and Rac2 was signiﬁcantly
enhanced by ectopic expression of ELMO1 (data not shown).
Thus, to determine whether ELMO1 and Rac2 copurify with
DOCK2, DOCK2-containing complexes were puriﬁed from
HEK 293 cells transiently expressing His-tagged DOCK2,
Myc-tagged ELMO1, and Myc-tagged Rac2 via DOCK2 using
Ni–NTA resin and eluted with imidazole. Immunoblotting
Figure 1. DOCK2, ELMO1, and Rac Are Abundant Nef-Associated Proteins
in T Cells
(A) Schematic representation of epitope-tagged HIV-1 Nef (NA7-hf).
The structured regions of Nef are boxed and the disordered regions,
as determined by X-ray crystallography and NMR studies, are shown
by a thin line. The locations of the N-terminal myristoyl moiety,
prolines P72 and P75 in the PP-II helix, arginine R106, leucines L164
and L165 (LL164), and the C-terminal HA-FLAG epitopes are
indicated.
(B) DOCK2, ELMO1, and Rac2 speciﬁcally copurify with HIV-1 Nef
from Jurkat T cells. Jurkat T cells (1.831010) stably expressing NA7-hf
(lane 3) or control Jurkat cells (lane 2) were subjected to the two-step
immunopuriﬁcation procedure described in the text (see Materials
and Methods). Polypeptides present in puriﬁed immune complexes
were resolved by SDS-PAGE and analyzed by LC/MS/MS. We
identiﬁed 58 DOCK2-speciﬁc peptides covering 869 out of 1830
total amino acid residues (47.5% coverage, expectation value 6.0 3
10–130), 10 ELMO1-speciﬁc peptides covering 122 out of 727 total
amino acid residues (16.8% coverage, expectation value 1.03 1010),
and three Rac-speciﬁc (two of which were Rac2-speciﬁc) peptides
covering 26 out of 192 total amino acid residues (13.5% coverage,
expectation value 4.6 3 104). Bands corresponding to DOCK2,
ELMO1, Rac2 and their predicted molecular weights, NA7-hf Nef,
and the FLAG peptide used for elution are indicated.
DOI: 10.1371/journal.pbio.0020006.g001
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revealed that ELMO1 and Rac2 copuriﬁed with DOCK2
(Figure 2A, lane 3), indicating that DOCK2 complexes with
ELMO1 (DOCK2–ELMO1) and Rac2.
Subsequently, we asked whether ELMO1 and Rac2 are
subunits of DOCK2–Nef complexes. DOCK2–Nef-containing
complexes were isolated from HEK 293 cells transiently
expressing His-tagged DOCK2, Myc-tagged ELMO1, Myc-
tagged Rac2, and HA-FLAG epitope-tagged HIV-1 Nef (NA7-
hf) via DOCK2 using Ni–NTA resin and eluted with imidazole
(Figure 2A, lane 4). DOCK2–Nef complexes were then
reisolated from this eluate via Nef by anti-FLAG immuno-
precipitation. It is evident that ELMO1 and Rac2 also
copuriﬁed with complexes containing both Nef and DOCK2
(Figure 2A, lane 6), thus supporting the possibility that HIV-1
Nef binds DOCK2–ELMO1 complexes that contain Rac2.
Nef Targets Rac1 and Rac 2 Isoforms
Our mass spectroscopic analyses indicated that HIV-1 Nef
associates with Rac2, but left open the possibility that it also
targets Rac1. Therefore, we tested whether Nef can associate
with Rac1 in the context of DOCK2 and ELMO1 using the
same HEK 293 transient expression assay. Nef and its
associated proteins were isolated from cell extracts by anti-
FLAG immunoprecipitation and visualized by immunoblot-
ting (Figure 2B). Nef formed readily detectable complexes
incorporating Rac1 (Figure 2B, lane 2), while a mutant Nef
protein unable to associate with membranes due to dis-
ruption of its N-terminal myristoylation signal (NA7(G2rHA)),
and therefore functionally defective, did not associate with
DOCK2, ELMO1, or Rac1 (Figure 2B, lane 3). These results
indicate that myristoylated Nef targets the Rac1 and Rac2
isoforms.
Nef proteins from well-characterized primate lentiviruses
display considerable amino acid sequence variation. There-
fore, we veriﬁed that Nef proteins from additional well-
characterized laboratory HIV-1 strains (SF2 and NL4–3) bind
DOCK2, ELMO1, and Rac2. We also tested a Nef protein from
Figure 2. Lentiviral Nef Binds the DOCK2–
ELMO1–Rac Complex
(A) HIV-1 Nef binds the DOCK2–EL-
MO1–Rac2 complex. His-DOCK2, Myc-
ELMO1, and Myc-Rac2 alone (lanes 1, 3,
and 5) or together with NA7-hf Nef
(lanes 2, 4, and 6) were transiently
expressed in HEK 293 cells as indicated.
DOCK2 was precipitated from extracts
(lanes 1 and 2) with Ni–NTA resin (lanes
3 and 4). Nef–DOCK2 was then precipi-
tated with anti-FLAG afﬁnity gel (lanes 5
and 6), and the epitope-tagged proteins
were detected by immunoblotting and
visualized by enhanced chemilumines-
cence.
(B) Rac1 associates with HIV-1 Nef. Nef
and associated proteins were isolated
from extracts of HEK 293 cells transi-
ently expressing DOCK2, ELMO1, and
Rac1 either alone (lanes 1 and 4), with
NA7-hf (lanes 2 and 5), or with a Nef
variant containing a disrupted myristoy-
lation signal (lanes 3 and 6). Nef and
associated proteins were detected in
anti-FLAG immunoprecipitates (lanes
1–3) and in extracts (lanes 4–6) by
immunoblotting.
(C) The interaction with DOCK2, EL-
MO1, and Rac2 is a conserved function
of lentiviral Nef proteins. The ability of
selected hf-tagged HIV-1 (lanes 1–3 and
5) and SIV mac239 (lane 4) Nef proteins
to bind DOCK2, ELMO1, and Rac2 was
determined as described in the legend to
(B) above. The protein band in (C)
indicated by the asterisk is the heavy
chain of anti-FLAG mAb.
DOI: 10.1371/journal.pbio.0020006.g002
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a strain of pathogenic SIV, mac239, that is important for
rapid progression to AIDS in experimentally infected rhesus
macaques (Kestler et al. 1991). Nef and its associated proteins
were isolated from HEK 293 cell extracts by anti-FLAG
immunoprecipitation and visualized by immunoblotting
(Figure 2C). Functional Nef proteins from all lentiviral strains
tested associated with DOCK2, ELMO1, and Rac2. This
indicates that the ability to associate with Rac and its
upstream regulators is a conserved function of primate
lentiviral Nef.
Nef Activates Rac in Resting T Cells
Since DOCK2, ELMO1, and Rac are major Nef-associated
proteins in Jurkat T cells and since DOCK2 mediates Rac
activation, we determined the effect of Nef on Rac activity in
these cells. The active GTP-bound form of Rac (RacGTP) binds
the p21-binding domains (PBD) of PAKs directly (Burbelo et
al. 1995). Hence, we used a PBD–GST fusion protein in
pulldown assays to measure the fraction of activated Rac in
vivo. Jurkat T cells were transduced with a lentiviral vector
directing the expression of HIV-1 Nef (FUGWCNA7) or a
control empty vector (FUGW). Extracts prepared from these
cells were incubated with PBD–GST and the fraction of PBD-
bound Rac was determined by immunoblotting (Figure 3A).
Notably, the expression of Nef resulted in a readily detectable
increase in the steady-state level of PBD-bound Rac (Figure
3A, lane 3), consistent with the possibility that the interaction
of Nef with DOCK2–ELMO1 increases Rac activation.
In nontransformed T lymphocytes, Rac activation through
DOCK2 is tied to chemotactic and antigenic stimuli. To assess
whether Nef can uncouple these processes, we determined
the effect of Nef on Rac activation in primary CD4þ T
lymphocytes in the absence of stimulation with antigen and
chemokines. While resting T cells are normally refractory to
productive infection by lentiviruses and lentivirus-derived
vectors, a sizable fraction becomes permissive for infection
when cultured in the presence of cytokines such as IL-7
(Unutmaz et al. 1999). We used this procedure to infect
primary resting CD4þ T lymphocytes with an HIV-1-derived
vector expressing HIV-1 NA7 Nef (H-NA7) or a control nef-
deleted vector (H-D). Since HIV-1 Env protein may activate
DOCK2-controlled signaling pathways through binding to
chemokine receptors such as CXCR4, env-defective, VSV-G-
pseudotyped viruses were used in these experiments. We
cultured 98% pure populations of CD4þ T cells isolated from
the peripheral blood leukocytes of healthy donors for 5 d in
the presence of IL-7 and then transduced them with Nef-
expressing H-NA7 or control H-D virus. The purity of the
infected populations and the efﬁciency of transduction were
assessed 4 d later by ﬂow cytometric analysis of CD4
expression on the cell surface and intracellular p24 Gag
expression, respectively. As shown in Figure 3B, between 13%
and 15% of CD4þ T cells were productively infected. Notably,
the unusually low level of CD4 on the surface of cells infected
with H-NA7 virus was due to robust downregulation of cell
surface CD4 by NA7 Nef (Mariani and Skowronski 1993). Cell
extracts were prepared from the infected populations, and
PBD–GST pulldown assays were performed to determine the
fraction of activated Rac. Strikingly, infection with H-NA7
resulted in a readily detectable increase in the steady state
level of activated Rac (Figure 3C). Based on direct quantita-
tions of chemiluminescent signals of total and PBD–GST
bound Rac, we estimated that approximately 1.2% of the total
Rac in extracts from cells transduced with H-NA7 was bound
to PBD–GST as compared to 0.2% in extracts from cells
transduced with H-D. The activation of Rac was speciﬁcally
due to the expression of Nef and not other viral gene
products, as infection with the otherwise isogenic H-D virus
did not increase PBD–GST-reactive Rac. To address the
speciﬁcity of Nef effect towards Rac, we then asked whether
Nef affects activity of CDC42 GTPase, which also uses PAK as
a downstream effector (Burbelo et al. 1995). Direct quanti-
tations of chemiluminescent signals for total and PBD–GST-
bound CDC42 revealed that less than 0.2% of the total
CDC42 in extracts from H-NA7 and H-D transduced cells was
PBD–GST bound. Therefore, we concluded that Nef primar-
ily activates Rac and not CDC42 in CD4þ T lymphocytes in
the absence of antigenic stimuli.
Figure 3. Nef Activates Rac in Resting CD4þ T Lymphocytes
(A) HIV-1 Nef activates Rac in Jurkat T cells. Jurkat T cells (lane 1)
were transduced with a control empty vector (FUGW; lane 2) or the
same vector expressing HIV-1 NA7 Nef (FUGWCNA7; lane 3). RacGTP
was precipitated from cell extracts with recombinant PAK1 PBD–
GST. PBD–GST bound RacGTP (top), total Rac present in extracts
(middle), and Nef (bottom) were detected by immunoblotting.
(B) Flow cytometric analysis of Gag and CD4 expression in resting
CD4þ T lymphocytes transduced with HIV-1 derived vectors in the
presence of IL-7. Percentages of cells productively infected with nef-
deleted H-D vector (boxed area in middle panel) or with HIV-1 NA7
nef containing H-NA7 vector (right panel) are shown. Results
obtained with uninfected control CD4þ T cells cultured in the
presence of IL-7 are also shown (left panel).
(C) HIV-1 Nef speciﬁcally activates Rac in resting primary CD4þ T
lymphocytes. RacGTP and CDC42GTP were precipitated with PAK1
PBD–GST from extracts prepared from CD4þ T lymphocytes
transduced with HIV-1 derived vectors, shown in (B), and analyzed
as described in (A).
DOI: 10.1371/journal.pbio.0020006.g003
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Next we asked whether Nef activates Rac through DOCK2–
ELMO1. To determine whether ELMO1 is required for the
effect of Nef, we measured Rac activation by Nef in NS1
lymphoma cells, which do not express the endogenous
ELMO1 (Sanui et al. 2003b) and in NS1 cells in which ELMO1
expression was restored by retrovirus-mediated transfer of
ELMO1 cDNA (NS1ELMO1). NS1 and NS1ELMO1 cells were
infected with a lentiviral vector expressing HIV-1 NA7 Nef
(FUGWCNA7) or with a control empty vector (FUGW). Cell
extracts were prepared from the infected populations, and
PBD–GST pulldown assays were performed to determine the
fraction of activated Rac. In agreement with a previous report
(Sanui at al. 2003b), NS1 cells contain a small but readily
detectable pool of activated Rac in spite of the lack of
detectable ELMO1 expression, which is most likely generated
by ELMO1-independent mechanism(s) (Figure 4A, lane 1).
Notably, expression of Nef in the absence of ELMO1 and
expression of ELMO1 in the absence of Nef did not increase
the fraction of activated Rac (compare lane 2 to lane 1 and
lane 3 to lane 1, respectively, in Figure 4A). In contrast,
expression of Nef in the presence of ELMO1 induced a
readily detectably increase in the pool of activated Rac in the
NS1ELMO1 cells (Figure 4A, lane 4). These observations
indicate that Nef activates Rac through an ELMO1-depend-
ent mechanism.
Next, we studied Rac activation by Nef in HEK 293 cells,
which do not express endogeneous DOCK2. Combinations of
Nef, DOCK2, ELMO1, and either Rac1 or Rac2 were
expressed in HEK 293 cells by transient transfection. The
expression of Nef in the absence of DOCK2 had little effect
on the activation of either Rac isoform (Figure 4B, lanes 2 and
7). Ectopic expression of DOCK2 and ELMO1 increased the
fraction of activated Rac1 and Rac2 by approximately 3- to 4-
fold (Figure 4B, lanes 3 and 8), which is in agreement with a
previous report (Sanui et al. 2003b). Signiﬁcantly, coexpres-
sion of myristoylated, but not unmyristoylated, Nef (Figure
4B, lanes 4 and 9 versus lanes 5 and 10) with DOCK2 and
ELMO1 further enhanced the fraction of activated Rac
isoforms by approximately 2-fold, and this effect of Nef was
more pronounced for Rac2 (compare lane 9 with lane 4 in
Figure 4B). Together, these data indicate that myristoylated
Nef stimulates Rac activation through the DOCK2–ELMO1
complex.
Nef Activates Rac through Association with DOCK2 and
ELMO1
We identiﬁed mutations in Nef that disrupt Rac activation.
Nef was reported to associate with an active form of PAK, and
this interaction was suggested to be important for Nef effects
on the cytoskeleton and T cell activation (Fackler et al. 1999;
Arora et al. 2000; Wang et al. 2000). Since PAK is an
immediate downstream effector of Rac, we asked whether the
abilities of Nef to activate Rac through DOCK2–ELMO1 and
to associate with activated PAK are correlated. Two different
Nef mutations that were previously reported to disrupt its
association with activated PAK (P72A,P75A and R106A)
(Sawai et al. 1995; Renkema and Saksela 2000), yet unlike
the myristoylation signal mutation (G2rHA) did not signiﬁ-
cantly affect Nef functions in other assays, were tested for
their effects on Rac activation in Jurkat T cells (Figure 5A)
and in HEK 293 cells transiently expressing DOCK2, ELMO1,
and Rac2 (Figure 5B). Both mutations abolished the ability of
Nef to stimulate Rac activation (Figures 5A and 5B, lanes 4
and 5). As expected, the same was true for mutation of the
myristoylation signal in Nef (Figures 5A and 5B, lane 3). In
contrast, a mutation that speciﬁcally abrogates the inter-
action of Nef with clathrin adaptor proteins (LL164AA;
Greenberg et al. 1998) had little disruptive effect on Rac
activation (Figures 5A and 5B, lane 6).
Next we asked whether mutations in Nef that disrupted
Rac2 activation affected the association with DOCK2,
ELMO1, and Rac2 (Figure 5C). The LL164AA mutation,
which did not signiﬁcantly compromise the stimulation of
Rac activation, did not affect the association of Nef with these
proteins (Figure 5C, lane 6). In contrast, mutations that
reduced Rac2 activation by Nef also diminished its associa-
tion with DOCK2, ELMO1, and Rac2 (Figure 5C, lanes 3–5).
Figure 4. ELMO1 and DOCK2 Mediate Rac Activation by HIV-1 Nef
(A) ELMO1 is required for Rac activation by Nef in NS1 cells. RacGTP
and total Rac in the extracts prepared from ELMO1-deﬁcient NS1
cells (lanes 1 and 2) and ELMO1-expressing NS1 cells (lanes 3 and 4)
following transduction with a lentiviral vector expressing HIV-1 Nef
(lanes 2 and 4) or a control empty vector (lanes 1 and 3) were
visualized as described in the legend to Figure 3.
(B) Nef activates Rac through DOCK2 and ELMO1 in HEK 293 cells.
RacGTP and total Rac in the extracts prepared from HEK 293 cells
coexpressing the indicated proteins were visualized as described
above.
DOI: 10.1371/journal.pbio.0020006.g004
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Notably, the P72A,P75A and R106A mutations completely
disrupted detectable association with ELMO1 and Rac2, but
only weakened that with DOCK2, suggesting that Nef
associates with both DOCK2 alone and DOCK2 complexed
with ELMO1 and/or Rac2 and that the P72A,P75A and R106A
mutations preferentially disrupt binding to the latter com-
plex. Thus, robust stimulation of Rac2 activation by Nef
requires its association with both DOCK2 and ELMO1.
Functional Consequences of Nef Interactions with
DOCK2–ELMO1 and Rac
The CD4þ T lymphocyte is a major target of infection by
primate lentiviruses. Nef was reported to lower the threshold
signal required for antigen-induced responses of T cells
(Schrager and Marsh 1999; Wang et al. 2000), and this effect
was proposed to be an important component to stimulation
of viral replication by Nef in vivo (Alexander et al. 1994;
Simmons et al. 2001). Since DOCK2 mediates Rac activation
downstream of the TCR to modulate T cell responsiveness
and downstream of chemokine receptors to mediate chemo-
tactic responses (Fukui et al. 2001; Sanui et al. 2003a), we
studied effects of Nef on these processes in T lymphocytes.
Puriﬁed populations of primary resting CD4þ T cells were
transduced with VSV-G-pseudotyped H-NA7 or nef-deleted
H-D in the presence of IL-7. Cells were stimulated 4–6 d
following transduction with plate-bound anti-CD3 and anti-
CD28 antibodies, mixed at various ratios, for various amounts
of time. Intracellular IL-2 and p24 Gag were visualized and
quantiﬁed by ﬂow cytometry to provide a measure of cellular
activation of the infected cells in response to the stimulation.
In the absence of anti-CD3/anti-CD28 stimulation, neither
uninfected (Gag-negative) nor the productively infected (Gag-
positive) cells, produced detectable amounts of IL-2 (Figure
6). In contrast, stimulation through CD3 and CD28 induced
readily detectable accumulation of IL-2 in both H-D- and H-
NA7-transduced populations. Notably, a larger fraction of
productively infected CD4þ T lymphocytes typically pro-
ceeded to express IL-2 than uninfected cells. This phenom-
Figure 5. Nef Potentiates Rac Activation
through Association with DOCK2–ELMO1
(A and B) Myristoylation signal, P72,P75,
and R106 in Nef are required for Rac
activation. RacGTP and total Rac in the
extracts prepared from Jurkat T cells
transduced with lentiviral vectors ex-
pressing no Nef () or the indicated
Nef proteins (A) and HEK 293 cells
transiently coexpressing the indicated
Nef mutants together with DOCK2,
ELMO1, and Rac2 (B) were visualized as
described in the legend to Figure 3 and
quantiﬁed by direct imaging of chemilu-
minescent signals. The fraction of total
Rac present in the extracts that was
PBD–GST bound is shown in the histo-
grams. Data in the histogram shown in
(B) are averages of three independent
experiments and error bars represent
two standard deviations.
(C) Myristoylation signal, P72,P75, and
R106 in Nef are required for association
with DOCK2, ELMO1, and Rac2. The
ability of selected Nef mutants to asso-
ciate with DOCK2, ELMO1, and Rac2
was determined as described in Figure 2.
DOI: 10.1371/journal.pbio.0020006.g005
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enon suggests that the permissive state for HIV-1 infection
induced by IL-7 is associated with an increased responsive-
ness to activation via CD3 and CD28. However, no signiﬁcant
difference in the levels of IL-2 expression in cells infected
with H-D compared to those infected with H-NA7 was
detected across a wide range of stimulation conditions. These
observations contrast with results from previous studies using
T cell lymphoma and nontransformed CD4þ T lymphocytes
expressing Nef alone (Schrager and Marsh 2000; Wang et al.
2001). This difference could, for example, reﬂect the
modifying effect of other HIV-1 gene products that were
not tested in the previous experiments. On the other hand,
we cannot exclude the possibility that IL-7 treatment masks
the effect of Nef. Since Nef deregulates DOCK2 function and
DOCK2 is essential for proper signaling through the
immunological synapse, further studies under a variety of
conditions that modulate the formation and function of the
immunological synapse may be required to reveal this effect
of Nef in the context of HIV-1 infection.
DOCK2 regulates the activation of Rac proteins during
lymphocyte migration in response to chemokine gradients
(Fukui et al. 2001). Therefore, we also asked whether Nef
affects lymphocyte chemotaxis. Jurkat T cells, which con-
stitutively express CXCR4, a major coreceptor for T-cell
tropic HIV and a receptor for stromal-derived factor 1 (SDF-
1) (Deng et al. 1996; Feng et al. 1996), were transiently
transfected with a control plasmid expressing enhanced
green ﬂuorescent protein (GFP) alone or with a plasmid that
coexpresses Nef and a GFP marker protein from the same
bicistronic transcription unit. We then measured the chemo-
taxis of transfected populations to SDF-1 using a transwell
migration assay. The relative frequency of control and Nef-
expressing cells in the migrated populations was determined
by ﬂow cytometric measurement of GFP expression. Approx-
imately 30% of control cells migrated regardless of the level
of GFP expression, indicating that the chemotaxis in this
assay was robust (Figure 7A). In contrast, the chemotaxis of
cells coexpressing Nef and GFP was inhibited in a dose-
dependent manner.
Control experiments revealed that Nef caused a modest
decrease in cell surface expression of CXCR4 (compare
panels 1 and 2 in Figure 7B). This observation raised the
possibility that Nef-expressing cells were unresponsive to
SDF-1 due to abnormally low levels of CXCR4 at the cell
surface rather than due to deregulation of the DOCK2–
ELMO1 complex. To address this possibility, we restored
CXCR4 on the surface of Nef-expressing cells to levels equal
to and even higher than those seen in control cells by
transiently expressing ectopic CXCR4 receptor and then
performed migration assays using these cell populations
(Figure 7B, panels 3 and 4). Signiﬁcantly, the migration of
cells with restored CXCR4 levels was still inhibited by Nef
expression (Figure 7A). We concluded that HIV-1 Nef blocks
lymphocyte migration to SDF-1 principally by interfering
with CXCR4-controlled signaling cascades rather than by
downregulating CXCR4 from the cell surface.
Figure 6. Effect of Nef on IL-2 Expression in HIV-1-Infected CD4þ T
Lymphocytes Stimulated through CD3 and CD28
CD4þ T lymphocytes transduced with H-D and H-NA7 HIV-1-derived
vectors were not stimulated (unstimulated) or stimulated with
immobilized anti-CD3 and anti-CD28 mAbs (anti-CD3, anti-CD28)
in the presence of Golgi-Stop for 5 h and stained for intracellular IL-
2 and p24 Gag. Percentages of IL-2-positive and IL-2-negative cells in
the Gag-negative and Gag-positive populations are shown.
DOI: 10.1371/journal.pbio.0020006.g006
Figure 7. Nef Disrupts T Cell Migration to SDF-1
(A) Migration of cell populations shown in (B) expressing GFP (open
circle), ectopic CXCR4, and GFP (ﬁlled circle), HIV-1 NA7 Nef and
GFP (open box), HIV-1 NA7 Nef, ectopic CXCR4 and GFP (ﬁlled box)
to SDF-1 was measured in transwell assays.
(B) Transient expression of ectopic CXCR4 restores CXCR4 levels on
the surface of Nef-expressing cells. Flow cytometric analysis of Jurkat
T cells transiently expressing GFP (panel 1) or HIV-1 NA7 Nef and
GFP (panel 2) and together with ectopic CXCR4 (panels 3 and 4,
respectively).
DOI: 10.1371/journal.pbio.0020006.g007
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We then asked whether inhibition of Jurkat T cell
migration by Nef correlated with its ability to potentiate
Rac activation by DOCK2 and ELMO1. As expected, we found
that disruption of the myristoylation signal in Nef
(NA7(G2rHA)) abolished the inhibition of migration (Figure
8A and 8B). Furthermore, the P72A,P75A, and R106A
mutations diminished the ability of Nef to block migration,
albeit to different extents. In contrast, the LL164AA
mutation, which had little disruptive effect on enhancement
of Rac activation, was fully functional in this assay. These
observations suggested that deregulated activation of Rac
GTPases is instrumental for the defective migration of Nef-
expressing cells. To explore this possibility further, we
ectopically expressed constitutively active Rac1 and Rac2
(Rac1G12V, Rac2G12V) and, as controls, wild-type Rac1 and
Rac2 in Jurkat T cells and measured their migration to SDF-1
(Figure 8C). Expression of wild-type Rac GTPases stimulated
chemotaxis approximately 2- to 3-fold. In contrast, expres-
sion of the constitutively active forms of each Rac GTPase
severely suppressed lymphocyte migration to SDF-1. Thus,
deregulated Rac activation inhibits directional cell move-
ment, most likely by disrupting spatially organized rearrange-
ments of the cytoskeleton that are induced by chemokine
gradients. These results further support a model in which Nef
disrupts migration to SDF-1 by activating Rac through the
DOCK2–ELMO1 module and thus uncoupling Rac activation
from chemokine receptor signaling.
The above observations predicted that Nef likely causes a
general migration defect. Therefore, we also studied the
effect of Nef on Jurkat T cell migration to the MIP-1b
chemokine. Since the MIP-1b receptor (CCR5) is not
constitutively expressed in Jurkat T cells, we transiently
expressed CCR5 and GFP marker from a bicistronic vector
either alone or together with HIV-1 NA7 Nef. Using this
vector, CCR5 expression levels were positively correlated with
GFP marker protein expression (Figure 9A, panels 2 and 3).
Notably, ﬂow cytometric analysis revealed that CCR5 cell-
surface expression was not downregulated by Nef (compare
panels 5 and 6 in Figure 9A). We then measured the ability of
these cells to migrate to MIP-1b. Migration of cells coex-
pressing CCR5 and HIV-1 Nef was impaired compared to
control cells expressing CCR5 at comparable levels (Figure
9B). These data conﬁrm that Nef induces a general defect in
lymphocyte migration by targeting DOCK2–ELMO1 and Rac.
Discussion
Nef is a multifunctional adaptor protein that modulates
signal transduction and protein-sorting machineries. We
puriﬁed to near homogeneity an abundant Nef-associated
protein complex from T cells and identiﬁed by mass
spectroscopy its major subunits as DOCK2 and ELMO1, a
bipartite Rac activator (Sanui et al. 2003b). Notably, the
extensive large-scale biochemical puriﬁcation and sensitive
proteomic analyses described in this report did not detect
Figure 8. Nef Disrupts Chemotaxis by Activating Rac through DOCK2–
ELMO1
(A and B) Jurkat T cells expressing wild-type or mutant HIV-1 Nef
proteins and GFP reporter were used in transwell chemotaxis assays
with SDF-1. Percentage of migrated cells expressing GFP alone (open
circle), or together with HIV-1 NA7 (open square), NA7(G2rHA) (open
diamond), NA7(P72A,P75A) (open triangle), NA7(R106A) (ﬁlled circle), and
NA7(LL164AA) (ﬁlled triangle) is shown as a function of GFP
ﬂuorescence intensity in (A) and in (B) for the single GFP
ﬂuorescence intensity interval indicated by the shaded rectangle in
(A).
(C) Constitutively active Rac GTPases disrupt lymphocyte migration
to SDF-1. Migration of Jurkat T cells transiently expressing wild-type
(Rac1, Rac2), constitutively active (Rac1G12V, Rac2G12V), or as a
control HIV-1 Nef were also measured. Data shown are averages of
three independent experiments and error bars represent two
standard deviations.
DOI: 10.1371/journal.pbio.0020006.g008
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several cellular proteins previously reported to associate with
HIV-1 Nef and mediate the effects of Nef in the cell (data not
shown). This includes cellular proteins such as Vav (Fackler et
al. 1999), PAKs (Sawai et al. 1995), inositol triphosphate
receptor (Manninen and Saksela 2002), Lck protein-tyrosine
kinase (Baur et al. 1997), clathrin adaptors (Greenberg et al.
1997; Le Gall et al. 1998; Piguet et al. 1998), and others.
Why were proteins previously reported to associate with
Nef not detected in our studies? One possible explanation is
that previously reported associations are unstable under the
biochemical puriﬁcation conditions used in our studies. This
likely explains the apparent absence of clathrin adaptors in
Nef preparations puriﬁed in our studies, since we know that
Nef binds AP-2/AP-1 clathrin adaptors only weakly in the salt
and pH conditions used here (data not shown). It is also
possible that in some cases, epitope tags may be buried and
therefore inaccessible to the monoclonal antibodies (mAbs)
used for immunoafﬁnity puriﬁcation. Moreover, some of the
previously reported associations, especially those with pro-
tein kinases, such as PAKs, were best detected by an
ultrasensitive in vitro kinase assay (Sawai et al. 1995) and, as
our data show, are likely of exceedingly low stoichiometry.
(Of note, we did detect the presence of p62 phosphoprotein
[PAK] by in vitro kinase assays of anti-Nef puriﬁcations [data
not shown]). Finally, some of the described associations, such
as that with thioesterase, are known to occur only with
selected Nef variants (Cohen et al. 2000), while those we
report here occur with all Nef variants tested. Nonetheless,
the speciﬁc isolation of the Nef–DOCK2–ELMO1–Rac com-
plex reported here provides strong biochemical evidence to
reinforce predictions from previous genetic studies that Nef
functions through multiple independent interactions with
different sets of downstream effector proteins.
Our observations strongly argue that DOCK2–ELMO1 is
the major upstream regulator used by Nef to activate Rac in T
cells and that through this interaction Nef can activate Rac in
CD4þ T lymphocytes even in the absence of stimulation with
antigen or chemokines. These data indicate that Nef targets a
critical switch, DOCK2–ELMO1, that regulates Rac GTPases
downstream of chemokine receptors and the TCR and uses it
to modulate the downstream processes they control. Thus,
the interaction of Nef with DOCK2 and ELMO1 provides an
important mechanism by which Nef may impact pathogenesis
by primate lentiviruses.
Our data strongly suggest that DOCK2–ELMO1 is the
major activator of Rac targeted by Nef in T lymphocytes. This
model is supported by the observations that Nef physically
associates with a complex that contains DOCK2–ELMO1 and
Rac, that speciﬁc mutations in Nef simultaneously disrupt its
ability to bind this complex and to activate Rac, and that Nef
fails to activate Rac in the absence of ELMO1. Although
previous reports implicated Vav, a Rac1 guanine nucleotide
exchange factor (GEF), as the critical downstream effector
that Nef binds directly to activate PAK (Fackler et al. 1999),
our data do not support this possibility. Notably, we have
been unable to detect the presence of Vav in anti-Nef
immune complexes by both proteomic analyses and immu-
noblotting, indicating that these interactions are of low
abundance relative to those with DOCK2 and ELMO1 and are
therefore unlikely to mediate the bulk of Nef’s impact on the
Rac pathway. Signiﬁcantly, ELMO1 is ubiquitously expressed
(Gumienny et al. 2001) and can associate with Nef in
nonlymphoid cells in the absence of DOCK2 (data not
shown). Thus, we postulate a general mechanism in which
ELMO1, possibly in complex with another CDM family
protein, mediates Rac activation and PAK recruitment by
Nef that is observed in nonlymphoid cells (Sawai et al. 1995;
Fackler et al. 1999; Arora et al. 2000).
Our observation that the expression of Nef from the
integrated HIV-1 provirus in primary CD4þ T cells did not
alter IL-2 production in standard activation protocols was
unexpected, because previous genetic evidence linked Nef
binding to DOCK2–ELMO1 and the ensuing activation of Rac
GTPases to the the ability of Nef to facilitate T cell activation.
Speciﬁcally, the same mutations that we observed to disrupt
Rac activation through the DOCK2–ELMO1 complex were
Figure 9. HIV-1 Nef Disrupts CCR5-Mediated Migration
(A) HIV-1 Nef does not downregulate CCR5. Flow cytometric analysis
of CCR5 and GFP in Jurkat T cells transiently expressing GFP alone
(panel 1) or CCR5 and GFP in the absence (panel 2) and presence
(panel 3) of HIV-1 Nef. Histograms of CCR5 expression for cell
populations within a single GFP ﬂuorescence intensity interval
indicated by the rectangle in panel 1 are shown in panels 4 to 6,
respectively.
(B) Percentage of cells migrated to MIP-1b and expressing GFP alone
(open circle), GFP and CCR5 (open triangle), or GFP, CCR5 and HIV-
1 Nef (ﬁlled triangle) is shown as a function of GFP ﬂuorescence
intensity.
DOI: 10.1371/journal.pbio.0020006.g009
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previously reported to disrupt the stimulatory effect of Nef
on aspects of T cell activation (Sawai et al. 1995; Simmons et
al. 2001), and the observed effects were in some cases
dramatic (Wang et al. 2000). Moreover, Rac activation by
DOCK2 facilitates T cell responsiveness to antigen, as
disrupted Rac activation in DOCK2(/) and Rac2(/) mice
is associated with defective immunological synapse formation
and depressed antigen-speciﬁc responses (Yu et al. 2001;
Sanui et al. 2003a). Since Nef deregulates DOCK2 function
and DOCK2 is essential for proper signaling through the
immunological synapse, further studies under a variety of
conditions that modulate the formation and function of the
immunological synapse may be required to reveal the effect
of Nef in the context of HIV-1 infection.
Interestingly, the chemokine receptor system plays crucial
roles in infection by primate lentiviruses. Previous studies
revealed its essential role for virus entry into target cells
(Deng et al. 1996; Feng et al. 1996). Primate lentiviruses also
exploit this system to recruit uninfected target cells to sites of
viral replication (Weissman et al. 1997; Swingler et al. 1999).
Our observations reveal an additional level of complexity in
primate lentivirus–chemokine receptor system interactions.
Inhibiting chemotaxis of the infected T cells likely disrupts
the generation of the immune response. During generation of
the immune response, T cells are initially activated in the
paracortex of lymph nodes and then migrate to the edges of
follicles, where they interact with antigen receptor-activated
B cells (Garside et al. 1998). This physical interaction is
required to drive B cells towards antibody production,
isotype switching, and the afﬁnity maturation of the antibody
response. Hence, the development and maturation of the
immune response require the ordered migration of activated
T cells to speciﬁc sites within lymphoid tissue (Delon et al.
2002). Notably, recent in vivo evidence documents Nef-
dependent alterations in the distribution of SIV mac239-
infected CD4þ T lymphocytes in the lymph nodes of
experimentally infected rhesus macaques (Sugimoto et al.
2003). In lymph nodes of monkeys infected with nef-deleted
SIV, most infected T cells were located in the B cell-rich
follicles and in the border region between the paracortex and
the follicles. In contrast, in monkeys infected with SIV
harboring a functional nef gene, most productively infected
T cells remained in the T cell-rich paracortex and were only
infrequently present in proximity to B cell follicles. This
evidence shows that Nef disrupts the ordered migration
patterns of infected CD4þ T lymphocytes in vivo and
reinforces the possibility that this disruption impairs the
generation and maturation of the immune response to
antigens. Since a large fraction of HIV-1-infected CD4þ T
cells is speciﬁc for HIV-1 antigens (Douek et al. 2002), this
effect of Nef provides another mechanism to suppress the
antiviral immune response. Taken together, the functional
interaction of Nef with DOCK2, ELMO1, and Rac enables Nef
to modulate multiple aspects of T cell function.
Materials and Methods
Construction of expression plasmids. Sequences encoding variant
and mutant Nef proteins tagged at their C-termini with a peptide (hf)
containing the HA and FLAG epitopes (DTYRYIYANATYPYDVP-
DYAGDYKDDDDK) were subcloned into pBABE-puro and pCG
expression plasmids (Morgenstern and Land 1990; Greenberg et al.
1998). In NA7(G2rHA) Nef, the myristoylation signal was disrupted by
insertion of the HA epitope (ANATYPYDVPDYAG) at glycine G2.
The full-length human ELMO1 cDNA (clone IMAGE:4521393;
ResGen, Carlsbad, California, United States), DOCK2 cDNA
(KIAA0209, clone ha04649; Kazusa DNA Research Institute, Chiba,
Japan), and cDNAs encoding wild-type and mutant forms of Rac1 and
Rac2 (kindly provided by Linda Van Aelst, Cold Spring Harbor
Laboratory, Cold Spring Harbor, New York, United States) were
subcloned into pCG plasmids containing N-terminal c-Myc (EQKLI-
SEEDL) or polyhistidine (HHHHHHH) epitope tags, using standard
techniques. pBABE ELMO1 contains an N-terminal c-Myc epitope-
tagged ELMO1 cDNA subcloned into the pBABE-neo vector. H-NA7
was constructed by substituting the HIV-1 NL4–3 nef coding sequence
with that of HIV-1 NA7 nef (Mariani and Skowronski 1993) in pNL4–3
carrying a frameshift mutation at the KpnI site at position 6463 in
env, kindly provided by Klaus Strebel (National Institute of Allergy
and Infectious Diseases, National Institutes of Health, Bethesda,
Maryland, United States). H-D is based on H-NA7 with a deletion that
removes residues 1–34 of Nef and prevents expression of Nef protein.
For chemotaxis assays, cDNAs encoding HIV-1 NA7 Nef, human
CCR5 (kindly provided by Frank Kirchhoff, Universita¨tsklinikum,
Ulm, Germany), and Rac proteins were subcloned into the pCGCG
bicistronic vector that directs the expression of GFP from an internal
ribosomal entry site element (Lock et al. 1999).
Generation of stable cell lines. pBABE plasmids were introduced
into the Phoenix amphotropic packaging cell line, kindly provided by
G. P. Nolan (Stanford University Medical Center, Palo Alto,
California, United States), by calcium phosphate coprecipitation,
and viral supernatants were used to infect a Jurkat T cell subline
(Greenberg et al. 1998), provided by Dan R. Littman (New York
University School of Medicine, New York, New York, United States),
or NS1 cells. Transduced Jurkat cells were selected and subsequently
maintained in the presence of puromycin (0.4 lg/ml) (Sigma, St.
Louis, Missouri, United States). Transduced NS1 cells were selected
and maintained in the presence of G418 (1.0 mg/ml) (Invitrogen,
Carlsbad, California, United States).
Immunoafﬁnity puriﬁcation of epitope-tagged Nef and associated
proteins. Unless stated otherwise, all reactions were performed at
48C. Approximately 1.83 1010 Jurkat T cells stably expressing NA7-hf
(or control cells) were lysed for 1 h in 200 ml of LB buffer (150 mM
NaCl, 50 mM Tris–HCl [pH 7.5], 1% Triton X-100, 10% glycerol)
(Complete Protease Inhibitors, Roche, Basel, Switzerland). Extracts
were precleared with protein G–agarose (Roche) for 1 h and
incubated with 12CA5 mAb crosslinked to protein G–agarose beads
for 4 h. The immunoprecipitate was washed extensively with LB, and
bound proteins were eluted by competition with HA peptide (0.2 mg/
ml) (ANATYPYDVPDYAG; Invitrogen) in LB for 45 min at 308C. The
eluate was incubated with anti-FLAG M2 afﬁnity gel beads (Sigma)
overnight, and the immunoprecipitate was washed extensively with
LB and then LB modiﬁed to contain 0.1% Triton X-100 (FEB buffer).
Proteins were eluted with FEB containing FLAG peptide (0.2 mg/ml)
(Sigma) for 45 min at 308C. The eluate was concentrated on Microcon
centrifugal ﬁlter devices (Millipore, Billerica, Massachusetts, United
States) with a cutoff of 8 kDa.
Protein identiﬁcation by mass spectrometry. Nef and associated
proteins were separated by 8%–17% SDS-PAGE and visualized using
SYPRO stain (Molecular Probes, Eugene, Oregon, United States).
Visible bands were excised and processed for identiﬁcation by mass
spectrometry. The samples were analyzed by LC-MS/MS as described
previously (Hu et al. 2002). Spectra resulting from LC/MS/MS were
analyzed with the SONARS software package (ProteoMetrics LLC,
New York, New York, United States).
Lentiviral vectors and infections. FUGWCNA7 contains the wild-
type HIV-1 NA7 nef coding sequence under control of the CMV
promoter, subcloned downstream of the Woodchuck-responsive
element in the FUGW lentiviral vector (Lois et al. 2002). FUGWC
vectors containing amino acid substitutions in Nef have a similar
structure. Supernatants containing infectious particles were pro-
duced by calcium phosphate cotransfection of HEK 293 cells, as
described previously (Lois et al. 2002). For biochemical analyses of
Rac activation, approximately 107 Jurkat T cells or NS1 cells were
infected with supernatants containing approximately 107 infectious
units of FUGW or FUGWC vectors encoding wild-type or mutant
HIV-1 NA7 Nef proteins, in the absence of polycationic agents. Cell
extracts were prepared 3–4 d following infection and used for PBD–
GST pulldown assays. PBMCs were puriﬁed from buffy coats of
healthy donors (New York Blood Bank, Hicksville, New York, United
States) by density gradient separation on Lymphocyte Separation
Medium (ICN Biomedicals, Inc., Irvine, California, United States), and
CD4þ T lymphocytes were isolated using CD4þ T Cell Enrichment
Columns (R&D Systems, Minneapolis, Minnesota, United States).
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Replication incompetent HIV-1 particles pseudotyped with VSV-G
were produced by calcium phosphate transfection of HEK 293 cells
and used to infect .98% pure populations of CD4þ T lymphocytes
that were cultured in the presence of IL-7 (Unutmaz et al. 1999). Cell-
surface CD4 in the infected populations was revealed with FITC-
conjugated SK3 mAb (Becton Dickinson, San Jose, California, United
States). Cells stained for CD4 were permeabilized using Cytoﬁx/
Cytoperm Kit (BD PharMingen, San Jose, California, United States)
and p24 Gag expression was revealed with PE-conjugated KC57-RD1
mAb (Beckman Coulter, Inc., San Diego, California, United States) as
described elsewhere (Mascola et al. 2002). CD4 and Gag expression
were quantitated simultaneously using an LSR-II ﬂow cytometer
(Becton Dickinson).
Cell stimulations and IL-2/Gag assays. Anti-CD3 mAb and anti-
CD28 mAb (MAB100 and MAB342; R&D Systems), alone or in
combinations, were immobilized on 12-well microtiter plates (351143;
Becton Dickinson) in PBS overnight at 48C. Wells were washed three
times with PBS, and 53 105 CD4þ T lymphocytes were added 4–5 d
after they were transduced with H-D or H-NA7 vectors in the
presence of IL-7. In some experiments, transduced cells were
cultured for additional 48 h in the absence of IL-7 before
stimulations. Stimulations were performed for 4 h to 16 h in the
presence and absence of Golgi-Stop (Becton Dickinson). Cells were
recovered from wells by vigorous pipetting, ﬁxed, and permeabilized
using Cytoﬁx/Cytoperm Kit (BD Bioscience PharMingen). Intra-
cellular IL-2 and p24 Gag were revealed simultaneously with PE-
conjugated rat anti-human IL-2 mAb, (559334; B&D Biosciences
PharMingen) and FITC-conjugated KC57-RD1 mAb (Beckman
Coulter, Inc.), respectively.
Transient transfections of HEK 293 cells, immunoprecipitations,
and immunoblotting. HEK 293 cells were transfected by calcium
phosphate coprecipitation with 20 lg of pCG plasmids expressing
epitope-tagged DOCK2, ELMO1, Rac2 or Rac1, and/or tagged Nef
proteins and a control empty vector. Cells were lysed 48 h
posttransfection in LB buffer. To isolate Nef and associated proteins,
extracts were incubated overnight with anti-FLAG M2 Afﬁnity Gel
(Sigma), the immunoprecipitates were washed four times with LB
buffer, once with LB containing 0.5 M LiCl, and proteins were eluted
with FLAG peptide as described above. To isolate DOCK2 and
associated proteins, extracts were incubated with Ni–NTA agarose
(Qiagen, Valencia, California, United States) and proteins were eluted
from the precipitate with 250 mM imidazole. DOCK2–Nef complexes
were isolated from imidazole eluates with anti-FLAG M2 afﬁnity gel
as described above. Eluted proteins proteins were separated by 16%
SDS-PAGE, electroblotted onto PVDF membrane (Millipore), and
immunoblotted with the following antibodies: anti-c-Myc mAb (1:100;
Oncogene, Tarrytown, New York, United States), anti-FLAG M2 mAb
(1:5000; Sigma), 12CA5 mAb (1:5000), or rabbit serum raised to a
DOCK2-speciﬁc peptide (GDKKTLTRKKVNQFFKTM). Immune
complexes were revealed with HRP-conjugated antibodies speciﬁc
for the Fc fragment of mouse or rabbit immunoglobulin G. (1:5,000;
Jackson ImmunoResearch Laboratories, Inc., West Grove, Pennsylva-
nia, United States) and ECL (Amersham, Little Chalfort, United
Kingdom).
Rac and CDC42 activity assays. Cells were lysed in LB modiﬁed to
contain 500 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, and 10
mM MgCl2 (RB buffer). Extracts were incubated for 2 h with 40 lg of
recombinant PAK1 PBD–GST (kindly provided by Linda Van Aelst)
bound to glutathione–agarose beads (8 mg/ml) (Roche), and beads
were washed extensively with RB buffer. Bound proteins and aliquots
of extracts were separated by 16% SDS-PAGE. Rac was immuno-
blotted with anti-c-Myc epitope mAb (1:100; Oncogene), or with anti-
Rac mAb (1:1000; BD Transduction Laboratories), CDC42 was
detected with sc-87 rabbit antibody (1:100; Santa Cruz Biotechnology,
Santa Cruz, California, United States), and Nef was detected with
rabbit serum raised against HIV-1 HxB3 Nef (1:300; Mariani and
Skowronski 1993). Immune complexes were visualized by chemilu-
minescence using Lumi-Lite Plus (Roche). Chemiluminescent signals
were imaged and quantitated using the FluorChem Imaging System
and software (Alpha Innotech, Cannock, United Kingdom).
Chemotaxis assays. Jurkat T cells were transfected by electro-
poration with plasmids coexpressing Nef and GFP marker protein
from a single bicistronic transcription unit (pCGCG NA7; Lock et al.
1999), except that in some experiments were also cotransfected with
pCG CXCR4, expressing human CXCR4 receptor. Transfected
populations were used 24–48 h later in transwell chemotaxis assays
in the presence of 10 ng/ml of SDF-1 (R&D Research). For CCR5-
dependent migration, Jurkat T cells were transfected with pCGCG
CCR5, expressing human CCR5 and GFP, alone or in the presence
pCG NA7, and migration to MIP-1b (10 ng/ml) was measured. Cells
were allowed to migrate for 2 h, and the relative frequency of GFP-
positive cells in the initial and migrated populations was determined
by ﬂow cytometry using an LSR-II ﬂow cytometer (Becton Dickinson).
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